EFTR Live signaler | Maksimer profitt med Getagraph.com

SELG 109477 min ago

@ $11.19

Utstedt: 13 feb 2024 @ 16:58

Avkastning: -82.42%

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 18:32):

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer...

Stats
Dagens volum	78 916.00
Gjennomsnittsvolum	382 382
Markedsverdi	7.26M
EPS	$-3.42 ( 2024-03-27 )
Neste inntjeningsdato	( $-2.17 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0.0120 (0.61%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-19	Loewy Caroline M	Buy	2 000	Stock Option (Right to Buy)
2024-02-19	Bhatt Elizabeth	Buy	2 000	Stock Option (Right to Buy)
2024-02-19	Ehrlich Christopher B	Buy	2 000	Stock Option (Right to Buy)
2024-02-19	Klencke Barbara	Buy	2 000	Stock Option (Right to Buy)
2024-02-19	Harrington-smith Kristen	Buy	2 000	Stock Option (Right to Buy)

INSIDER POWER
45.06
Last 95 transactions
Buy: 5 541 401 \| Sell: 1 016 887

Volum Korrelasjon

Lang: -0.17 (neutral)

Kort: -0.06 (neutral)

Signal:(48.59) Neutral

eFFECTOR Therapeutics, Korrelasjon

10 Mest positive korrelasjoner
APOP	0.91
FLGT	0.875
PIII	0.875
PRSR	0.871
MAGS	0.871
SOFIW	0.867
CMLF	0.867
LPTX	0.864
AGCUU	0.863
WKSP	0.863

10 Mest negative korrelasjoner
ULTA	-0.855
IEP	-0.845
TNDM	-0.833
IART	-0.83
ASO	-0.829
CDAK	-0.828
IQ	-0.827
PAYS	-0.827
SBNYP	-0.817
PHCF	-0.815

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

eFFECTOR Therapeutics, Korrelasjon - Valuta/Råvare

0.32
( neutral )

0.58
( weak )

0.00
( neutral )

0.65
( weak )

0.64
( weak )

-0.67
( moderate negative )

eFFECTOR Therapeutics, Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2023
Omsetning:	$0
Bruttogevinst:	$-111 000 (0.00 %)
EPS:	$-16.37

FY	2022
Omsetning:	$3.55M
Bruttogevinst:	$3.50M (98.51 %)
EPS:	$-7.85

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$1.050

Financial Reports:

No articles found.

eFFECTOR Therapeutics,

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California.